With revenues declining and net losses increasing, Seattle-based Adaptive Biotechnologies on Thursday said it hired Goldman Sachs to help conduct… Read More
Adaptive Biotechnologies, which develops technology to assess the immune response, posted $154.3 million in revenue last year, a 57% year-over-year… Read More
Seattle-based Adaptive Biotechnologies, which develops technology to sequence the human immune system to diagnose and treat disease, posted revenue of… Read More
https://www.youtube.com/watch?v=zJASgbcWVUc&feature=emb_title Microsoft and Seattle’s Adaptive Biotechnologies are seeking 1,000 people across the country for a “virtual clinical study” designed to… Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering.… Read More
